Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00037843
Status:
COMPLETED
Last Update Posted:
2012-02-22
First Post:
2002-05-23
Brief Title:
Iodine I-131 Iodocholesterol Its Use in Adrenal Screening
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Study Overview
Official Title:
Iodine I-131 Iodocholesterol Its Use in Adrenal Screening
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a clinical research study using I-131 Iodocholesterol which is an experimental radioactive chemical that when injected into the vein is picked up in the adrenal glands and permits visualization with gamma imaging devices These images are used in diagnosing a variety of adrenal abnormalitiesPrior to the injection of I-131 Iodocholesterol the patient will receive perchlorate capsules to block any uptake of I-131 by the thyroid gland if this is deemed important The patient will continue to take these capsules throughout the period of imaging which may last up to 1 week The injection of I-131 Iodocholesterol will be given into a vein and the patient will return for images on at least 1 and possibly 2 occasions between 3-7 days after injection If the case requires it the patient may also be given a steroid in tablet form dexamethasone to take orally prior to and after the injection to suppress normal adrenal function so that the abnormal tissues can be more easily detected
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None